Advertisement

Topics

ContraVir Names Robert Foster Acting CEO in Executive Shuffle

11:41 EDT 10 Oct 2018 | Xconomy

Robert Foster is now acting CEO of ContraVir Pharmaceuticals (NASDAQ: CTRV). Foster, ContraVir’s chief scientific officer for the past two years, succeeds James Sapirstein, who had been the Edison, NJ, company’s chief executive since 2014. According to a securities filing, Sapirstein resigned as a director of the company effective Oct. 2. No reason for the […]

Original Article: ContraVir Names Robert Foster Acting CEO in Executive Shuffle

NEXT ARTICLE

More From BioPortfolio on "ContraVir Names Robert Foster Acting CEO in Executive Shuffle"

Advertisement
Quick Search
Advertisement
Advertisement